Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell C Benson

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Journal of Endourology|July 30, 2011
Impact of HMG-CoA reductase inhibitor (statin) use on blood loss during robot-assisted and open radical prostatectomyMatthew D Truesdale, Allison R Polland, Joseph A Graversen, et al.
The Journal of Urology|March 31, 2015
Predicting Renal Parenchymal Loss after Nephron Sparing SurgeryAlexa Meyer, Solomon L Woldu, Aaron C Weinberg, et al.
The Journal of Urology|September 28, 2011
Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapyMatthew S Wosnitzer, Josep Domingo-Domenech, Mireia Castillo-Martin, et al.
Urologic Oncology|July 24, 2004
A contemporary evaluation of cytoreductive nephrectomy with tumor thrombus: Morbidity and long-term survivalManlio A Goetzl, Erik T Goluboff, Alana M Murphy, et al.
Cancer|July 1, 2011
A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancerMatthew S Wosnitzer, Gregory W Hruby, Alana M Murphy, et al.
BJU International|September 6, 2007
High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomyPhillip M Pierorazio, Sarah M Lambert, Mahesh Matsukhani, et al.
Urologic Oncology|November 23, 2005
A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: a Southwest Oncology Group StudyMichael F Sarosdy, Catherine M Tangen, Geoffrey R Weiss, et al.
Urology|September 28, 2014
Who really benefits from nephron-sparing surgery?Solomon L Woldu, Aaron C Weinberg, Ruslan Korets, et al.
Journal of Endourology|September 19, 2013
Comparison of robot-assisted and open retropubic radical prostatectomy for risk of biochemical progression in men with positive surgical marginsEdan Y Shapiro, Kyle Scarberry, Trushar Patel, et al.
Urology|March 18, 2003
Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancerScott M Gilbert, Robert W Veltri, Alex Sawczuk, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Journal of Endourology|July 30, 2011
Impact of HMG-CoA reductase inhibitor (statin) use on blood loss during robot-assisted and open radical prostatectomyMatthew D Truesdale, Allison R Polland, Joseph A Graversen, et al.
The Journal of Urology|March 31, 2015
Predicting Renal Parenchymal Loss after Nephron Sparing SurgeryAlexa Meyer, Solomon L Woldu, Aaron C Weinberg, et al.
The Journal of Urology|September 28, 2011
Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapyMatthew S Wosnitzer, Josep Domingo-Domenech, Mireia Castillo-Martin, et al.
Urologic Oncology|July 24, 2004
A contemporary evaluation of cytoreductive nephrectomy with tumor thrombus: Morbidity and long-term survivalManlio A Goetzl, Erik T Goluboff, Alana M Murphy, et al.
Cancer|July 1, 2011
A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancerMatthew S Wosnitzer, Gregory W Hruby, Alana M Murphy, et al.
BJU International|September 6, 2007
High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomyPhillip M Pierorazio, Sarah M Lambert, Mahesh Matsukhani, et al.
Urologic Oncology|November 23, 2005
A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: a Southwest Oncology Group StudyMichael F Sarosdy, Catherine M Tangen, Geoffrey R Weiss, et al.
Urology|September 28, 2014
Who really benefits from nephron-sparing surgery?Solomon L Woldu, Aaron C Weinberg, Ruslan Korets, et al.
Journal of Endourology|September 19, 2013
Comparison of robot-assisted and open retropubic radical prostatectomy for risk of biochemical progression in men with positive surgical marginsEdan Y Shapiro, Kyle Scarberry, Trushar Patel, et al.
Urology|March 18, 2003
Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancerScott M Gilbert, Robert W Veltri, Alex Sawczuk, et al.
Pageof 14